3 completed. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 2 | Completed 2 |
Follow BenevolentAI Bio: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study Investigating the Safety, Tolerability, PK and Food Effect of BEN8744. BEN8744, Matching Placebo - Healthy Volunteer Study | Phase 1 | Completed | BenevolentAI Bio | 76 | 2023-08-30 | 2025-05-07 |
| A First-in-Human PoC Study With BEN2293 in Patients With Mild to Moderate Atopic Dermatitis BEN2293 (0.25% or 1.0% w/w) or matching placebo - Atopic Dermatitis | Phase 1 / Phase 2 | Completed | BenevolentAI Bio | 123 | 2020-10-14 | 2023-06-18 |
| BEN-2001 in Parkinson Disease Patients With Excessive Daytime Sleepiness BEN-2001, Placebo - Excessive Daytime Sleepiness, Parkinson Disease | Phase 2 | Completed | BenevolentAI Bio | 244 | 2017-11-10 | 2025-03-10 |
Dermatitis, Atopic (1) · Disorders of Excessive Somnolence (1) · Parkinson Disease (1)
bavisant (1)
United Kingdom (2) · United States (1)
Alexander Thompson, MBBS (1) · Denisa Wilkes (1) · William G Ondo, M.D (1)